|
We urge the Senate to oppose the passage of the pending U.S. Senate
Bill S. 507. We hold that Congress, before, embarking on a revision
of our time tested patent system, should hold extensive hearings on
whether there are serious flaws in the present system that need to be
addressed and if so, how best to deal with them. This is especially
important considering that a delicate structure such as the patent
system, with all its ramifications, should not be subject to frequent
modifications. We believe that S. 507 could result in lasting harm to
the United States and the world.
First, it will prove very damaging to American small inventors and
thereby discourage the flow of new inventions that have contributed
so much to America's superior performance in the advancement of
Science and technology. It will do so by curtailing the protection
they obtain through patents relative to the large multi-national
corporations.
Second, the principle of prior user rights saps the very spirit of that
wonderful institution that is represented by the American patent
system established in the Constitution in 1787, which is based on the
principle that the inventor is given complete protection but for a
limited length of time, after which the patent, fully disclosed in the
application and published at the time of issue, becomes in the public
domain, and can be used by anyone, under competitive conditions for
the benefit of all final users. It will do so by giving
further protection to trade secrets which can be kept secret forever, while reducing the incentive to rely on limited life patents.
Nobel Laureates in support of the letter to Congress. re: Senate Bill 507
Sidney Altman, (1989, Chemistry) Yale
Herbert C. Brown, (1979, Chemistry) Purdue
Robert F. Curl, (1996, Chemistry) Rice
Gertrude Elion, (1988, Medicine) Wellcome Research Laboratories
Jerome Friedman, (1990, Physics) MIT
Milton Friedman, (1976, Economics) University of Chicago
John C. Harsanyi, (1994, Economics) UC Berkeley
Herbert Hauptman, (1985, Chemistry) Hauptman-Woodward Medical Research Institute
Dudley Herschbach, (1986, Chemistry) Harvard
Roald Hoffman, (1981, Chemistry) Cornell
Henry Kendall, (1990, Physics) MIT
Har Gobind Khorana, (1968, Medicine) MIT
David M. Lee, (1996, Physics) Cornell
Merton Miller, (1990, Economics) U. of Chicago
Franco Modigliani, (1985, Economics) MIT
Mario Molina, (1995, Chemistry) MIT
Daniel Nathans, (1978, Medicine) Johns Hopkins
Douglass North, (1993, Economics) Washington University
Paul Samuelson, (1970, Economics) MIT
William Sharpe, (1990, Economics) Stanford
Clifford Shull, (1994, Physics) MIT
Herbert A. Simon, (1978, Economics) Carnegie-Mellon
Richard Smalley, (1996, Chemistry) Rice
Robert Solow, (1987, Economics) MIT
James Tobin, (1981, Economics) Yale
|